Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Ability of Nafamostat Mesilate to Prolong Filter Patency during Continuous Renal Replacement Therapy in Patients at High Risk of Bleeding: A Randomized Controlled Study

Figure 1

Enrollment, randomization, and follow up.

Out of 162 patients who were eligible to the study, 73 patients were enrolled in the study, and 60 patients completed the study for analysis.

Figure 1

doi: https://doi.org/10.1371/journal.pone.0108737.g001